Cite
MLA Citation
G. Burmester et al.. “FRI0216 Long-Term Safety and Efficacy of Mavrilimumab, A Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-Alpha Monoclonal Antibody, in Patients with Rheumatoid Arthritis.” Annals of the rheumatic diseases, vol. 75, n.d., p. 510. http://access.bl.uk/ark:/81055/vdc_100135145872.0x000051